000 | 01433cam a2200193 4500 | ||
---|---|---|---|
001 | NMDX6078 | ||
008 | 120401t2011 xxu||||| |||| 00| 0 eng d | ||
020 | _a9781906985448 | ||
080 | _aWP 145 GYN | ||
100 | _aKehoe, Sean | ||
245 |
_aGynaecological cancers _bbiology and therapeutics |
||
260 |
_bRCOG Press _c2011 |
||
500 | _aMonograph | ||
500 | _a259 p.; 23 cm | ||
520 | _a<span style="line-height: 19.5px;"><span style="font-size: 8pt; background-color: #ffffff;">Gynaecological cancers are categorised as 'rare' diseases, although collectively they affect over 16,000 women each year in the UK alone. There is a lack of real understanding of these conditions compared with other malignancies, possibly owing to their relative rarity when viewed as individual diseases. The 60th RCOG Study Group brought together a range of experts to examine as many biological aspects of gynaecological cancers as possible, including both surgical and non-surgical therapies. This book presents the findings of the Study Group, with contents including: • current understanding of the biology of gynaecological cancers • translation of biology to the clinic • state of the art in imaging and therapy • current clinical trials • advances in multimodal therapy • individualised treatment.</span></span> | ||
700 | _aEdmondson, Richard J. | ||
700 | _aGore, Martin | ||
700 | _aMcNeish, Iain A. | ||
999 |
_c75461 _d75461 |